NGFR and ovarian carcinoma: Several inhibitors of NGF and NGF receptors, such as Ro 08-2750 (targets NGF), K252a (targets TrkA) and LM11A-31 (targets P75), have been shown to increase β-catenin expression and cell migration in ovarian cancer cells [89].